Europe Diet Pills Market

Worldwide Demand For Europe Diet Pills Has Projected To Register A Positive CAGR Of 2.6% During 2021-2031 | Fact.MR Forecasts

Key Takeaways

– Glucomannan is expected to contribute more than 41% revenue share in the market by 2031. – Among all the drug type, demand for herbal supplements is expected to increase at a CAGR of 3% through 2031. – Appetite controlling pills dominate the market among the mechanisms, and are expect to reach a valuation of US$ 595 Mn by 2031. – The U.K. holds the highest share in the Europe diet pills market, while Germany is the next leading country, with these markets expected to progress at 3.6% and 3% CAGRs, respectively.

Key Players

– GlaxoSmithKline plc. – Cheplapharm Arzneimittel GmbH – Holland & Barrett Retail Limited – Cresent Pharma. – Currax Pharmaceuticals LLC (OREXIGEN THERAPEUTICS IRELAND LTD) – Himalaya Wellness (The Himalaya Drug Company) – Nature’s Way Products, LLC – zeinpharma – SimplySupplements – Lindens Health + Nutrition

Analyst View

“Growing prevalence of obesity, unhealthy lifestyle, and rising awareness regarding preventive health are factors that have changed the focus of the pharmaceutical industry towards the development of weight loss pills,” says an analyst of Fact.MR.

Explore Fact.MR’s Domain Coverage On Healthcare